News

Green Griffith Partners Are 2018 Life Sciences Stars

Green Griffith is pleased to announce that founding partners Bob Green, Chris Griffith and Caryn Borg-Breen have been na…
Read More >

Caryn Borg-Breen: Putting the Intellect into IP Law Practice

Green Griffith is pleased to announce that founding partner, Caryn Borg-Breen, has been featured in Leading Lawyers 2018…
Read More >

Bob Green Named One of The Best Lawyers in America 2019

Green Griffith is pleased to announce that founding partner Bob Green has been selected by his peers for inclusion in Th…
Read More >

Caryn Borg-Breen to Speak at Chicago Women in Law Conference

Green Griffith is pleased to announce that founding partner, Caryn Borg-Breen, will participate in a panel discussion ex…
Read More >

Chris Griffith Speaks at 3rd Annual China Pharma IP Summit

This event focused on a variety of IP topics pertinent to pharma stakeholders located in Asia, including pharma-related …
Read More >

District Court Finds Safe Harbor Defense Does Not Apply to Continued Process Verification Program Undertaken by Biosimilar Applicant

The Biologics Price Competition and Innovation Act of 2009 (“BPCIA”) creates an artificial act of infringe…
Read More >

U.S. News Ranks Green Griffith as One of Nation’s Best

Green Griffith has received the following rankings in the 2019 edition of U.S. News – Best Lawyers® “…
Read More >

Burden to Rebut Obviousness in IPR Proceedings May Properly Be Placed on Patentee in the Context of Overlapping Prior Art Numerical Ranges

Under Federal Circuit precedent, a presumption of obviousness typically exists when numerical ranges recited in a claim …
Read More >

Federal Circuit Confirms Standing to Appeal IPR Decision in Absence of Infringement Lawsuit

In a September 17, 2018, decision (E.I. DuPont de Nemours v. Synvina, Appeal No. 2017-1977, available here), the Federal…
Read More >

SCOTUS Signals Interest in Case Concerning Standing to Appeal PTAB Final Written Decisions

The Supreme Court recently ordered briefing from the Solicitor General concerning RPX’s petition for a writ of ce…
Read More >

USPTO Changes Claim Construction Standard for Patent Trial and Appeal Board (PTAB) Proceedings

The USPTO, in a final rule (a copy of which may be accessed here), has changed the claim construction standard to be use…
Read More >

Federal Circuit Denies Petition for Rehearing En Banc of Vanda Pharmaceuticals Decision Concerning the Patentability of Method of Treatment Claims Under Section 101

The Federal Circuit’s April 13, 2018, Vanda decision (a copy may be found here) affirmed the district courtȁ…
Read More >